Some of America’s top scholars on prescription drug pricing outline steps the Trump administration could take to make medicines more affordable.
Articles
Posted inInsurance
Watch: Obamacare Subsidies at a Crossroads
Experts discuss what the loss of Obamacare subsidies means to patients and costs within the ACA insurance marketplace.
Posted inMental Health
This Federal Experiment Is Pouring Money into Mental Hospitals. Will It Work?
As states struggle to meet the needs of people with serious mental illness, some are signing on to a federal pilot project that’s pouring new funding into institutional care.
Posted inMental Health
One Scientist’s Mission to Change How We Prevent Overdoses
A leading addiction expert explains how he’s driven by the memory of a friend who died, and why he believes giving data on the drug supply to people on the street is more important than using it to inform national drug policy.
Posted inInsurance
A Rural Hospital in Kentucky Prepares for Medicaid Losses
Harrison Memorial Hospital in Cynthiana is already taking a hard look at its budget in light of Republican cuts to Medicaid.
Posted inHealth Equity
‘I Feel Unsafe Almost Everywhere’: How Trump Has Changed Life for One Transgender Teen
A conversation with an 18-year-old and her dad about how anti-trans policies have impacted their lives in 2025.
Posted inInsurance
Former North Carolina Health Secretary Sees Hard Road Ahead for States
Sweeping federal reforms force North Carolina and other states to make tough decisions about Medicaid coverage, costs and eligibility under mounting budget pressure.
Posted inPublic Health
Global Health, Research and Trump Dominate Aspen Ideas: Health Conference
Our reporters offer key takeaways from one of the biggest health care events of the year.
Posted inInsurance
Watch Tradeoffs and Penn Experts Discuss the Health Impacts of the “One Big Beautiful Bill”
As the U.S. Senate opens debate on a sweeping budget reconciliation bill passed by the House in May, leading health care scientists are warning that the legislation—formally titled the “One […]
Posted inPublic Health
Trump’s Policies Could Undermine the Fight to End America’s HIV Epidemic
The White House is asking Congress to sharply roll back federal spending on HIV prevention, a reversal from President Trump’s first term, when he championed investment to end the epidemic in America within a decade.